AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ilika plc

$0.32 -$0.19 (-37.31%)
OTC · 15 Sep 2026 14:35 UTC
Previous Close
$0.32
Day Range
$0.28$0.33
Year Range
$0.28$0.69
Market Cap
63.09M
AVG Volume
43.16K
Trailing/Forward PE
-5.96/-
PEG ratio
2.2
Dividend Yield
-
Next Earnings Date
2027-01-21
Primary Exchange
Other OTCUS
Revenue (GBP)
0250K500K750K1M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Revenue (GBP) by quarter
PeriodRevenue (GBP)
26 Q4470.1K
26 Q24.5K
25 Q4800
25 Q2982.1K
24 Q4755.5K
24 Q26.5K
23 Q433.85K
23 Q2203.7K
22 Q414.95K
22 Q215.93K
Net Income (GBP)
-6M-4M-2M022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Net Income (GBP) by quarter
PeriodNet Income (GBP)
26 Q4-3.58M
26 Q2-3.66M
25 Q4-3.68M
25 Q2-2.22M
24 Q4-2.23M
24 Q2-2.59M
23 Q4-3.22M
23 Q2-4.08M
22 Q4-3.86M
22 Q2-3.27M
Operating Income (GBP)
-6M-4M-2M022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Operating Income (GBP) by quarter
PeriodOperating Income (GBP)
26 Q4-4.47M
26 Q2-5.07M
25 Q4-4.54M
25 Q2-3.09M
24 Q4-3.16M
24 Q2-4.49M
23 Q4-4.47M
23 Q2-5.27M
22 Q4-4.92M
22 Q2-3.66M
EBITDA (GBP)
-6M-4M-2M022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF EBITDA (GBP) by quarter
PeriodEBITDA (GBP)
26 Q4-3.76M
26 Q2-3.38M
25 Q4-3.4M
25 Q2-2.21M
24 Q4-2.77M
24 Q2-2.14M
23 Q4-3.17M
23 Q2-4.24M
22 Q4-3.87M
22 Q2-2.95M
Cash Flows (GBP)
-6M-4M-2M022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Cash Flows (GBP) by quarter
PeriodCash Flows (GBP)
26 Q4-1.28M
26 Q2-4.18M
25 Q4-1.22M
25 Q2-3.87M
24 Q4-1.04M
24 Q2-2.52M
23 Q4-2.73M
23 Q2-4.72M
22 Q4-4.25M
22 Q2-5.83M
EPS (GBP)
-0.03-0.02-0.01022 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF EPS (GBP) by quarter
PeriodEPS (GBP)
26 Q4-0.02
26 Q2-0.02
25 Q4-0.02
25 Q2-0.01
24 Q4-0.01
24 Q2-0.02
23 Q4-0.02
23 Q2-0.03
22 Q4-0.02
22 Q2-0.02
Expenses (GBP)
02.5M5M7.5M10MR&DSG&ACapex22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Expenses (GBP) by quarter
PeriodExpenses (GBP)
26 Q49.32M
26 Q24.28M
25 Q44.31M
25 Q24.32M
24 Q48.23M
24 Q23.39M
23 Q48.06M
23 Q25.25M
22 Q49.66M
22 Q26.66M
Cash & Debt (GBP)
010M20M30MCashLong Term DebtShort Term Debt22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Cash & Debt (GBP) by quarter
PeriodCash & Debt (GBP)
26 Q45.35M
26 Q26.92M
25 Q47.98M
25 Q210.13M
24 Q411.95M
24 Q213.24M
23 Q415.87M
23 Q218.61M
22 Q423.45M
22 Q227.7M
Debt ratios
0123422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Debt ratios by quarter
PeriodDebt ratios
26 Q40.34
26 Q20.56
25 Q40.71
25 Q20.93
24 Q40.92
24 Q20.95
23 Q41.07
23 Q21.41
22 Q42.35
22 Q23.85
Margins
-150000%-100000%-50000%0%50000%22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Margins by quarter
PeriodMargins
26 Q466.73%
26 Q2-30876.93%
25 Q4-125874.88%
25 Q256.32%
24 Q479.21%
24 Q2-28593.85%
23 Q4-3118.05%
23 Q2-346.61%
22 Q4-5658.54%
22 Q2-4034.28%
Return on Capital
-30%-20%-10%0%22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Return on Capital by quarter
PeriodReturn on Capital
26 Q4-24.82%
26 Q2-20.67%
25 Q4-21.44%
25 Q2-10.69%
24 Q4-10.94%
24 Q2-11.51%
23 Q4-12.98%
23 Q2-14.77%
22 Q4-12.28%
22 Q2-9.32%
Shares Outstanding
050M100M150M200M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Shares Outstanding by quarter
PeriodShares Outstanding
26 Q4180.98M
26 Q2178.69M
25 Q4168.11M
25 Q2166.12M
24 Q4159.11M
24 Q2158.78M
23 Q4158.68M
23 Q2158.51M
22 Q4157.43M
22 Q2148.83M
Book Value Per Share (GBP)
00.10.20.322 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Book Value Per Share (GBP) by quarter
PeriodBook Value Per Share (GBP)
26 Q40.08
26 Q20.1
25 Q40.1
25 Q20.12
24 Q40.13
24 Q20.14
23 Q40.16
23 Q20.17
22 Q40.2
22 Q20.24
Total Assets (GBP)
010M20M30M40M22 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q226 Q4
ILIKF Total Assets (GBP) by quarter
PeriodTotal Assets (GBP)
26 Q416.77M
26 Q219.34M
25 Q419.45M
25 Q222.69M
24 Q422.83M
24 Q224.42M
23 Q426.91M
23 Q230.31M
22 Q433.93M
22 Q237.68M
Free Cash Flow Yield
-50%-40%-30%-20%-10%med -17.22%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ILIKF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-24.66%
Sep 26-24.43%
Sep 26-23.33%
Aug 26-22.08%
Aug 26-22.45%
Aug 26-24.56%
Aug 26-23.49%
Jul 26-22.73%
Jul 26-19.21%
Jul 26-20.96%
Jul 26-20.46%
Jul 26-20.06%
Jun 26-20.17%
Jun 26-18.61%
Jun 26-18.01%
Jun 26-16.47%
May 26-15.38%
May 26-17.22%
May 26-16.36%
May 26-15.73%
May 26-17.41%
Apr 26-16.61%
Apr 26-19.5%
Apr 26-22.19%
Apr 26-22.71%
Mar 26-22.51%
Mar 26-20.67%
Mar 26-19.39%
Mar 26-19.86%
Feb 26-19.7%
Feb 26-20.75%
Feb 26-20.9%
Feb 26-17.3%
Jan 26-18.8%
Jan 26-14.26%
Jan 26-14.01%
Jan 26-14.04%
Jan 26-13.69%
Dec 25-13.59%
Dec 25-13.5%
Dec 25-12.21%
Dec 25-12.33%
Nov 25-12.39%
Nov 25-12.42%
Nov 25-12.27%
Nov 25-11.46%
Oct 25-11.64%
Oct 25-11.74%
Oct 25-11.54%
Oct 25-10.91%
Oct 25-11.89%
Sep 25-10.39%
Sep 25-13.87%
Sep 25-14.25%
Sep 25-14.08%
Aug 25-13.9%
Aug 25-12.76%
Aug 25-12.24%
Aug 25-13.19%
Aug 25-11.68%
Jul 25-13.6%
Jul 25-13.39%
Jul 25-15.88%
Jul 25-15.33%
Jun 25-15.84%
Jun 25-17.09%
Jun 25-16.95%
Jun 25-18.61%
May 25-19.56%
May 25-18.01%
May 25-16.92%
May 25-16.55%
May 25-16.74%
Apr 25-14.82%
Apr 25-15.83%
Apr 25-19.41%
Apr 25-19.73%
Mar 25-16.15%
Mar 25-15.75%
Mar 25-18.48%
Mar 25-15.51%
Feb 25-14.63%
Feb 25-13.66%
Feb 25-14.51%
Feb 25-17.21%
Jan 25-21.28%
Jan 25-28.8%
Jan 25-33.36%
Jan 25-31.74%
Jan 25-32.29%
Dec 24-33.48%
Dec 24-33.09%
Dec 24-34.14%
Dec 24-35.11%
Nov 24-32.81%
Nov 24-32.86%
Nov 24-43.03%
Nov 24-37.42%
Nov 24-37.42%
Oct 24-34.5%
Price to Sales
20304050med 34.14Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ILIKF Price to Sales by quarter
PeriodPrice to Sales
Sep 2629.37
Sep 2629.65
Sep 2631.04
Aug 2632.79
Aug 2632.25
Aug 2629.49
Aug 2630.83
Jul 2631.87
Jul 2630.79
Jul 2628.22
Jul 2628.91
Jul 2629.49
Jun 2629.33
Jun 2631.79
Jun 2632.84
Jun 2635.93
May 2638.48
May 2634.35
May 2636.17
May 2637.6
May 2633.99
Apr 2635.61
Apr 2630.34
Apr 2626.66
Apr 2626.05
Mar 2626.28
Mar 2628.62
Mar 2630.52
Mar 2629.8
Feb 2630.04
Feb 2628.52
Feb 2628.3
Feb 2634.2
Jan 2631.47
Jan 2634.77
Jan 2635.42
Jan 2635.32
Jan 2636.22
Dec 2536.49
Dec 2536.73
Dec 2540.63
Dec 2540.22
Nov 2540.03
Nov 2539.94
Nov 2540.43
Nov 2543.29
Oct 2542.63
Oct 2542.26
Oct 2542.99
Oct 2545.44
Oct 2541.7
Sep 2547.73
Sep 2535.75
Sep 2534.8
Sep 2535.24
Aug 2535.67
Aug 2538.87
Aug 2540.52
Aug 2537.6
Aug 2542.46
Jul 2542.06
Jul 2542.71
Jul 2536.02
Jul 2537.3
Jun 2536.11
Jun 2533.47
Jun 2533.73
Jun 2530.73
May 2529.24
May 2531.75
May 2533.8
May 2534.56
May 2534.16
Apr 2538.6
Apr 2536.13
Apr 2529.46
Apr 2528.99
Mar 2535.42
Mar 2536.32
Mar 2530.95
Mar 2536.88
Feb 2539.1
Feb 2541.88
Feb 2539.42
Feb 2533.22
Jan 2526.88
Jan 2538.26
Jan 2533.03
Jan 2534.71
Jan 2534.12
Dec 2432.91
Dec 2433.29
Dec 2432.27
Dec 2431.38
Nov 2433.58
Nov 2433.53
Nov 2425.6
Nov 2429.44
Nov 2429.45
Oct 2431.93
Price to Book
12345med 3.1Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
ILIKF Price to Book by quarter
PeriodPrice to Book
Sep 262.97
Sep 263
Sep 263.14
Aug 263.31
Aug 263.26
Aug 262.98
Aug 263.12
Jul 263.22
Jul 263.03
Jul 262.78
Jul 262.85
Jul 262.9
Jun 262.89
Jun 263.13
Jun 263.23
Jun 263.54
May 263.79
May 263.38
May 263.56
May 263.7
May 263.35
Apr 263.51
Apr 262.99
Apr 262.62
Apr 262.57
Mar 262.59
Mar 262.82
Mar 263.01
Mar 262.93
Feb 262.96
Feb 262.81
Feb 262.79
Feb 263.37
Jan 263.1
Jan 263.53
Jan 263.6
Jan 263.59
Jan 263.68
Dec 253.71
Dec 253.73
Dec 254.13
Dec 254.08
Nov 254.07
Nov 254.06
Nov 254.11
Nov 254.4
Oct 254.33
Oct 254.29
Oct 254.37
Oct 254.62
Oct 254.24
Sep 254.85
Sep 253.63
Sep 253.53
Sep 253.58
Aug 253.62
Aug 253.95
Aug 254.12
Aug 253.82
Aug 254.31
Jul 253.6
Jul 253.66
Jul 253.08
Jul 253.19
Jun 253.09
Jun 252.87
Jun 252.89
Jun 252.63
May 252.5
May 252.72
May 252.89
May 252.96
May 252.93
Apr 253.31
Apr 253.09
Apr 252.52
Apr 252.48
Mar 253.03
Mar 253.11
Mar 252.65
Mar 253.16
Feb 253.35
Feb 253.59
Feb 253.37
Feb 252.84
Jan 252.3
Jan 251.88
Jan 251.62
Jan 251.7
Jan 251.67
Dec 241.62
Dec 241.63
Dec 241.58
Dec 241.54
Nov 241.65
Nov 241.65
Nov 241.26
Nov 241.45
Nov 241.45
Oct 241.57
Ilika plc
ILIKF
Stockpicker

Video analysis: ILIKF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ILIKF

Ilika completes government-backed battery programme with defence and e-bike interest

proactiveinvestors.co.uk · 10 Sep 2026

Ilika completes government-backed battery programme with defence and e-bike interest

Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A), the UK developer of solid-state battery technology, said it had successfully completed its grant-supported PRIMED programme to improve the performance of its Goliath 10Ah battery prototypes. The project drew interest from a UK defence agency, which gave positive feedback on the battlefield resilience of the Goliath cells, opening what the company described as ongoing commercial opportunities.

Ilika plc (ILIKF) Q4 2026 Earnings Call Transcript

seekingalpha.com · 1 Aug 2026

Ilika plc (ILIKF) Q4 2026 Earnings Call Transcript

Ilika plc (ILIKF) Q4 2026 Earnings Call Transcript

Ilika showed commercial progress in Stereax and Goliath solid-state battery businesses - ICYMI

proactiveinvestors.com · 1 Aug 2026

Ilika showed commercial progress in Stereax and Goliath solid-state battery businesses - ICYMI

Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) this week outlined continued commercial progress across its Stereax and Goliath solid-state battery businesses,...

Ilika showed commercial progress in Stereax and Goliath solid-state battery businesses - ICYMI

proactiveinvestors.co.uk · 1 Aug 2026

Ilika showed commercial progress in Stereax and Goliath solid-state battery businesses - ICYMI

Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) this week outlined continued commercial progress across its Stereax and Goliath solid-state battery businesses, with chief executive Graeme Purdy highlighting the company's transition into revenue generation alongside several commercial catalysts expected over the next 12 to 18 months. Purdy, in an interview in the Proactive studio, said the most significant development for the Stereax business had been its move into commercial production, with Ilika now supplying commercial-grade electrodes to Cirtec for incorporation into the M300 medical device product, which is expected to reach the market later this year.

Dow Jones drops over 600 points ahead of Fed decision

proactiveinvestors.com · 29 Jul 2026

Dow Jones drops over 600 points ahead of Fed decision

10am: Dow drops over 600 points at open Selling is dominating early stock trading on Wall Street, with the Dow Jones falling 611 points, or 1.16%, to...

Ilika targets first Stereax royalties as batteries enter customer testing

proactiveinvestors.com · 29 Jul 2026

Ilika targets first Stereax royalties as batteries enter customer testing

Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) flagged that it is now a revenue-generating business, with initial royalties from its miniature solid-state...

Ilika targets first Stereax royalties as batteries enter customer testing

proactiveinvestors.co.uk · 29 Jul 2026

Ilika targets first Stereax royalties as batteries enter customer testing

Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) flagged that it is now a revenue-generating business, with initial royalties from its miniature solid-state batteries expected to flow in the 2027 financial year as it moves from development towards commercial production. In the battery developer's results for the year to April 2026, it noted that production of Stereax batteries has already begun with US manufacturing partner Cirtec Medical, supplying samples for customer testing and making initial deliveries.

Ilika's £500k retail offer oversubscribed

proactiveinvestors.com · 8 Jul 2026

Ilika's £500k retail offer oversubscribed

Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A), the solid-state battery developer, said its retail offer was oversubscribed and raised around £500,000 through...

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.